![Susanne Lagerlund](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Susanne Lagerlund
Directeur Technique/Scientifique/R&D chez
CAMURUS AB
Fortune : 16 182 $ au 31/07/2026
Profil
Susanne Lagerlund worked as Vice President-Regulatory Affairs at Cantargia AB from 2020 to 2023.
Prior to that, the role of Director-Established Portfolio Management was held at LEO Pharma AB. Education includes a graduate degree from the University of Lund.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 250 ( 0% ) | 16 182 $ | 31/07/2026 |
Postes actifs de Susanne Lagerlund
| Sociétés | Poste | Début |
|---|---|---|
| CAMURUS AB | Directeur Technique/Scientifique/R&D | 01/01/2025 |
Anciens postes connus de Susanne Lagerlund
| Sociétés | Poste | Fin |
|---|---|---|
| CANTARGIA AB | Conseiller Juridique Général | 01/01/2023 |
LEO Pharma AB
 LEO Pharma AB LEO Pharma AB is an independent, Swedish research-driven pharmaceutical company specializing in dermatology, with a history spanning over 100 years from its origins in Copenhagen. The company is based in Malmö, Sweden. The company employs approximately 5,200 people worldwide and serves 92 million patients across 130 countries. LEO Pharma is majority-owned by the independent LEO Foundation, with Nordic Capital holding a minority stake. Its Nordic hub operates in Sweden, with about 25 employees focused on sales, marketing, medical affairs, and supply. The company’s product portfolio includes dermatological and thrombotic treatments. | Corporate Officer/Principal | - |
Formation de Susanne Lagerlund
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
29
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Camurus AB
 Camurus AB Pharmaceuticals: MajorHealth Technology Provides nanoscale drug delivery systems for development of high value therapeutics | Health Technology |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LEO Pharma AB
LEO Pharma AB LEO Pharma AB is an independent, Swedish research-driven pharmaceutical company specializing in dermatology, with a history spanning over 100 years from its origins in Copenhagen. The company is based in Malmö, Sweden. The company employs approximately 5,200 people worldwide and serves 92 million patients across 130 countries. LEO Pharma is majority-owned by the independent LEO Foundation, with Nordic Capital holding a minority stake. Its Nordic hub operates in Sweden, with about 25 employees focused on sales, marketing, medical affairs, and supply. The company’s product portfolio includes dermatological and thrombotic treatments. | |
Cantargia AB
 Cantargia AB Pharmaceuticals: MajorHealth Technology Creates and develops antibody therapeutics for the treatment of leukemia | Health Technology |
